Workflow
济川药业(600566) - 2020 Q1 - 季度财报
JUMPCANJUMPCAN(SH:600566)2020-04-24 16:00

Financial Performance - Net profit attributable to shareholders decreased by 9.02% to CNY 464,173,082.28 year-on-year[4] - Operating revenue decreased by 3.45% to CNY 2,007,716,959.83 compared to the same period last year[4] - Basic earnings per share decreased by 8.95% to CNY 0.570[4] - The weighted average return on equity decreased by 1.60 percentage points to 7.33%[4] - Total revenue for Q1 2020 was CNY 2,007,716,959.83, a decrease of 3.2% compared to CNY 2,079,421,398.60 in Q1 2019[19] - Operating profit for Q1 2020 was CNY 531,465,484.35, down from CNY 558,995,646.53 in Q1 2019, reflecting a decline of 4.9%[19] - Net profit for Q1 2020 was CNY 464,173,082.28, a decrease of 9.0% compared to CNY 510,176,114.21 in Q1 2019[19] - The total comprehensive income for Q1 2020 was CNY 464,173,082.28, compared to CNY 510,176,114.21 in Q1 2019, showing a decrease of about 9.0%[20] Assets and Liabilities - Total assets increased by 8.68% to CNY 9,416,437,422.92 compared to the end of the previous year[4] - Total assets increased to ¥9,416,437,422.92 from ¥8,664,643,251.42, reflecting a growth in overall financial position[12] - Total liabilities increased to ¥2,847,746,394.64 from ¥2,560,213,202.98, indicating a rise in financial obligations[15] - Total liabilities as of March 31, 2020, were CNY 585,087,809.11, compared to CNY 580,088,823.23 at the end of 2019[18] - Current assets totaled CNY 2,070,091,836.82 as of March 31, 2020, an increase from CNY 2,063,533,839.11 at the end of 2019[17] Cash Flow - Net cash flow from operating activities increased by 13.34% to CNY 704,706,525.38 year-on-year[4] - The company reported a net cash inflow from operating activities of CNY 704,706,525.38 for Q1 2020, an increase from CNY 621,788,135.93 in Q1 2019, reflecting a growth of approximately 13.3%[23] - The net cash flow from operating activities for Q1 2020 was -131,387,674.17 RMB, compared to 1,853,201.65 RMB in Q1 2019, indicating a significant decline[25] - The total cash inflow from operating activities was 11,164,553.28 RMB in Q1 2020, compared to 3,772,066.07 RMB in Q1 2019, showing growth in operational cash receipts[25] Shareholder Information - The total number of shareholders at the end of the reporting period was 51,016[8] - Jiangsu Jichuan Holding Group Co., Ltd. held 51.14% of the shares, with 15,000,000 shares pledged[8] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 15,520,101.25 during the reporting period[5] - Other income decreased by 63.36% to ¥14,375,550.66 primarily due to a reduction in government subsidies[10] Investment and Expenses - Investment income decreased by 65.82% to ¥1,206,175.14 due to reduced investment in financial products with temporarily idle raised funds[10] - Financial expenses increased by 243.55% to -¥15,059,267.38 due to increased interest income during the reporting period[10] - Research and development expense of CNY 54,826,228.53 for Q1 2020, up from CNY 52,924,547.49 in Q1 2019, indicating a focus on innovation[19] - The company incurred financial expenses of CNY -1,303,991.17 in Q1 2020, a significant improvement from CNY 5,734,098.34 in Q1 2019[22] Cash and Cash Equivalents - The company’s cash and cash equivalents were CNY 1,041,729,685.87 as of March 31, 2020, down from CNY 1,076,043,532.36 at the end of 2019[16] - Total cash and cash equivalents at the end of Q1 2020 amounted to 1,041,729,685.87 RMB, down from 551,507,058.30 RMB in Q1 2019[26] - The initial cash and cash equivalents balance at the beginning of Q1 2020 was 1,076,043,532.36 RMB, compared to 321,440,304.98 RMB in Q1 2019, indicating a strong starting position[26]